nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Ableism When Caring for a Patient Receiving Dialysis
|
Chao, Chia-Ter |
|
|
85 |
5 |
p. A13 |
artikel |
2 |
Differences in Postoperative Disposition by Kidney Disease Severity: A Population-Based Cohort Study
|
Harrison, Tyrone G. |
|
|
85 |
5 |
p. 589-602.e1 |
artikel |
3 |
Disorders of Volume: Core Curriculum 2025
|
Arora, Nayan |
|
|
85 |
5 |
p. 629-638 |
artikel |
4 |
Editorial Board
|
|
|
|
85 |
5 |
p. A4-A6 |
artikel |
5 |
Erratum regarding “Lupus Nephritis Patterns and Response to Type I Interferon in Patients With DNASE1L3 Variants: Report of Three Cases” (Am J Kidney Dis. 2024;84(6):791-797)
|
|
|
|
85 |
5 |
p. 666 |
artikel |
6 |
GLP-1 Receptor Agonists for CKD: Remaining Issues or Mission Complete?
|
Kosjerina, Vanja |
|
|
85 |
5 |
p. 537-539 |
artikel |
7 |
Hurried Conversation
|
Pawar, Aditya S. |
|
|
85 |
5 |
p. A11-A12 |
artikel |
8 |
In Reply to “The End-Stage Kidney Disease Discussion of Patient Life Goals Survey”
|
Gelfand, Samantha L. |
|
|
85 |
5 |
p. 658-659 |
artikel |
9 |
Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials
|
Chen, Jui-Yi |
|
|
85 |
5 |
p. 555-569.e1 |
artikel |
10 |
LB-04 Association Between Baseline Serum Creatinine/Cystatin C (SCR/CYS) Ratio and Adverse Events in Patients Receiving Cisplatin or Carboplatin: A Prospective Cohort Study
|
|
|
|
85 |
5 |
p. 669 |
artikel |
11 |
LB-01 Chlorthalidone Compared to Hydrochlorothiazide for the Prevention of Kidney Stones: A Secondary Analysis of the Diuretic Comparison Project
|
|
|
|
85 |
5 |
p. 668 |
artikel |
12 |
LB-06 Impact of Kidneyintelx on Targeted use of SGLT2I
|
|
|
|
85 |
5 |
p. 669-670 |
artikel |
13 |
LB-03 Influence of Kidney Function on Apixaban Pharmacokinetics, Pharmacodynamics and Hemorrhage
|
|
|
|
85 |
5 |
p. 668-669 |
artikel |
14 |
LB-05 Long-Term Efficacy and Safety in the Phase 3 Illuminate-B Trial of Lumasiran for Primary Hyperoxaluria Type 1 in Infants and Young Children
|
|
|
|
85 |
5 |
p. 669 |
artikel |
15 |
LB-07 Patients (PTS) in Duplex Achieved Partial or Complete Remission of Proteinuria Earlier and more Often with Sparsentan (SPAR) vs Irbesartan (IRB): Implications for Slowing Progression to Kidney Failure (KF) in Focal Segmental Glomerulosclerosis (FSGS)
|
|
|
|
85 |
5 |
p. 670 |
artikel |
16 |
LB-02 Re-Defining Carboplatin Dosage Using EGFR-Creatinine-Cystatin C Compared to Cockcroft Gault and Impact on Platinum-Associated Adverse Events
|
|
|
|
85 |
5 |
p. 668 |
artikel |
17 |
Machine Perfusion in Deceased Donor Kidney Transplantation: Editorial Summary of a Cochrane Review
|
Tingle, Samuel James |
|
|
85 |
5 |
p. 647-650 |
artikel |
18 |
Machine Perfusion in Deceased Donor Kidney Transplantation: Promises of Improved Outcomes but Gaps in Implementation
|
Sonnenberg, Elizabeth M. |
|
|
85 |
5 |
p. 651-653 |
artikel |
19 |
Masthead
|
|
|
|
85 |
5 |
p. A3 |
artikel |
20 |
Methods for Diagnosing Proteinuria—When to Use Which Test and Why: A Review
|
Hodel, Nikolai Carl |
|
|
85 |
5 |
p. 618-628 |
artikel |
21 |
National Kidney Foundation 2025 Spring Clinical Meeting Late-Breaking Abstracts April 9-13, 2025
|
|
|
|
85 |
5 |
p. 667 |
artikel |
22 |
Patient and Health Care Provider Perspectives on Showering for Patients With Hemodialysis Central Venous Catheters: A Survey Study
|
Collins, Jhonna |
|
|
85 |
5 |
p. 545-554.e1 |
artikel |
23 |
Phenotypic Heterogeneity of ADTKD-MUC1 Diagnosed Using VNtyper, a Novel Genetic Technique
|
Kachmar, Jessica |
|
|
85 |
5 |
p. 603-609.e1 |
artikel |
24 |
Prevalence of Severe Mental Illness and Its Associations With Health Outcomes in Patients With CKD: A Swedish Nationwide Study
|
Zhu, Nanbo |
|
|
85 |
5 |
p. 577-588.e1 |
artikel |
25 |
Progressive Kidney Dysfunction With Weight Loss: A Quiz
|
Girimaji, Niveditha |
|
|
85 |
5 |
p. A14-A16 |
artikel |
26 |
Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis
|
Mariani, Laura H. |
|
|
85 |
5 |
p. 610-617 |
artikel |
27 |
Recommendations to Advance Social Connectedness in End Stage Kidney Disease Care in a Post–COVID-19 Era
|
Washington, Tiffany R. |
|
|
85 |
5 |
p. 639-646 |
artikel |
28 |
Renal Arteriovenous Gradients for Greater Than 10,000 Circulating Proteins
|
Kim, Taesoo |
|
|
85 |
5 |
p. 659-662 |
artikel |
29 |
Revisiting Protein Restriction in Early CKD: Did We Get it Wrong?
|
Workeneh, Biruh T. |
|
|
85 |
5 |
p. 654-657 |
artikel |
30 |
Severe Mental Illness in CKD: Why it Matters
|
Hedayati, S. Susan |
|
|
85 |
5 |
p. 543-544 |
artikel |
31 |
Surveying the Medical Education Landscape: Perspectives on Nephrology Education Among Internal Medicine Residents
|
Tamargo, Christina L. |
|
|
85 |
5 |
p. 662-665 |
artikel |
32 |
Table of Contents
|
|
|
|
85 |
5 |
p. A7-A10 |
artikel |
33 |
The End-Stage Kidney Disease Discussion of Patient Life Goals Survey
|
Dahlerus, Claudia |
|
|
85 |
5 |
p. 658 |
artikel |
34 |
To Shower or Not to Shower? Personal Hygiene, Safety, and Patient Choice in Hemodialysis Catheter Care
|
Bobart, Shane A. |
|
|
85 |
5 |
p. 535-536 |
artikel |
35 |
Uromodulin and Risk of Upper Urinary Tract Infections: A Mendelian Randomization Study
|
Liyanarachi, Kristin Vardheim |
|
|
85 |
5 |
p. 570-576.e1 |
artikel |
36 |
Uromodulin: Is There a Causal Relationship With Urinary Tract Infection Risk?
|
Nanamatsu, Azuma |
|
|
85 |
5 |
p. 540-542 |
artikel |